UnitedHealth rebuts Justice Department allegations in $3.3B Amedisys deal
UnitedHealth Group says the Justice Department’s antitrust challenge to its proposed $3.3 billion purchase of Amedisys is wrong on the merits and threatens to deprive consumers of benefits from sharper competition in the hospice and home care market.The …